RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer

Guo Bing Zhang; Jian Chen; Lin Run Wang; Jun Li; Ming Wei Li; Nong Xu; Yang Wang; Jian Zhong Shentu

首页> 外文期刊>Cancer Chemotherapy and Pharmacology >RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer

【24h】

RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer

机译：吉西他滨/卡铂治疗的晚期非小细胞肺癌患者外周血与肿瘤组织中RRM1和ERCC1的表达

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Purpose To comparatively evaluate the prognostic or predictive value of ribonucleotide reductase M1 (RRM1) and excision repair cross-complementation 1 (ERCC1) gene expression in peripheral blood versus tumor tissue from patients with advanced non-small cell lung cancer (NSCLC) treated by gemcitabine/platinum chemotherapy.

机译：目的比较吉西他滨治疗晚期非小细胞肺癌（NSCLC）患者外周血与肿瘤组织中核糖核苷酸还原酶M1（RRM1）和切除修复交叉互补1（ERCC1）基因表达的预后价值或预测价值/铂化疗。

著录项

来源
《Cancer Chemotherapy and Pharmacology》 |2012年第5期|p.1277-1287|共11页
作者
Guo Bing Zhang; Jian Chen; Lin Run Wang; Jun Li; Ming Wei Li; Nong Xu; Yang Wang; Jian Zhong Shentu;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer. [J] . Guo Bing Zhang, Jian Chen, Lin Run Wang, Cancer chemotherapy and pharmacology. . 2012,第5期

机译：吉西他滨/卡铂治疗的晚期非小细胞肺癌患者外周血与肿瘤组织中RRM1和ERCC1的表达。
2. Randomized International Phase III Trial of ERCC1 and RRM1 Expression-Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non-Small-Cell Lung Cancer. [J] . Gerold Bepler, Charles Williams, Michael J Schell, Journal of Clinical Oncology . 2013,第19期

机译：ERCC1和RRM1表达为基础的化疗与吉西他滨/卡铂治疗晚期非小细胞肺癌的国际随机III期试验。
3. Randomized International Phase III Trial of ERCC1 and RRM1 Expression-Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non-Small-Cell Lung Cancer. [J] . Gerold Bepler, Charles Williams, Michael J Schell, Journal of Clinical Oncology . 2013,第19期

机译：随机的国际期III试验ERCC1和RRM1表达的化疗与吉西他滨/卡铂治疗晚期非小细胞肺癌。
4. Gene expression profiles predict survival of patients with advanced non-small cell lung cancers [C] . Harun Roslan, Hadi Jalal, Mhazir Nur Shukriyah, 2011 Fourth International Conference on Modeling, Simulation and Applied Optimization . 2011

机译：基因表达谱预测晚期非小细胞肺癌患者的生存
5. Symptoms Leading to Nutritional Risk in Advanced Non-Small Cell Lung Cancer Patients: The Importance of Nutritional Screening in the Advanced Lung Cancer Population [D] . Swinton, Nelda. 2009

机译：导致晚期非小细胞肺癌患者营养风险的症状：在晚期肺癌人群中进行营养筛查的重要性
6. Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer [O] . Gerold Bepler, Charles Williams, Michael J. Schell, -1

机译：基于ERCC1和RRM1表达的国际化III期化疗与吉西他滨/卡铂治疗晚期非小细胞肺癌的比较
7. Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer [O] . Gerold Bepler, Charles Williams, Michael J. Schell, 2013

机译：Arcc1和基于RRM1表达的化学疗法的随机国际期III试验与晚期非小细胞肺癌的吉西他滨/卡铂

RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅